Urinary Incontinence, Urge
61
6
8
36
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
16 trials with published results (26%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
8.2%
5 terminated out of 61 trials
87.8%
+1.3% vs benchmark
18%
11 trials in Phase 3/4
44%
16 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (61)
RCT on Multimodal Self-treatment for Women With Incontinence Using a Digital Health Application
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
rTMS in Overactive Bladder
TReating Incontinence for Underlying Mental and Physical Health
INTIBIA Pivotal Study
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)
Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)
A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections
Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
UCon Treatment of Overactive Bladder (OAB) in Males
Effectiveness of Magnetic Stimulation in the Treatment of Female UUI.
Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence
Prophylactic Analgesia for Bladder Botox Injections
Sling vs Botox for Mixed Incontinence
Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community Women
Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence
Safety and Performance of UCon Patch Electrode